Kimberly-clark Worldwide, Inc.

Kimberly-clark Corporation

Gary Lee Shanklin

Wen Zyo Schroeder

Michael John Rekoske

Kenneth John Zwick

Mike Thomas Goulet

David John Tyrrell

Thomas Joseph Dyer

Cynthia Watts Henderson

Brenda Marie Nelson

David Roland Otts

Bernard Joseph Minerath

Linda Susan Huard

Peter Lee Carson

Michael William Smaby

Michael John Smith

John Alexander Werner, Iv

Michael Payne

Margaret M Ward

Duane Gerard Krzysik

Dennis Stein Everhart

Paul John Serbiak

Frank Jerrel Akin

Chantel Spring Buhrow

Edwin G Greenman

Robert Cosmo DiLuccio

Mark Alan Burazin

Thomas Gerard Shannon

Paul Kerner Pauling

Kathy Geralyn Richardson

Benjamin Peter Sierra

Maung H Win

Thomas Kremer

John Paul David

Gary Vance Anderson

David T Floyd

Jessica Jan O'Connor

Vinay Kumar Rao

David Matthew VanBergen

Provided are tissue webs and products that have a modest degree of surface texture, but are still soft. In certain instances the tissue products and webs may also have good sheet bulk and low stiffness. For example, the tissue products may have good softness, such as a TS7 value (measured using the EMTEC Tissue Softness Analyzer) less than 11.0, and a textured surface, such as an R2 value from about 11,000 to about 20,000 (measured using an OpTiSurf tester). The foregoing tissue products may have a sheet bulk greater than about 8.0 cc/g and a Stiffness Index less than about 15.0. In certain instances the tissue product and webs may be through-air dried and may be either creped or uncreped.

Soft textured tissue

Low slough, high basis weight tissue webs and products are provided. The tissue webs generally have basis weights greater than about 16 grams per square meter (gsm), while maintaining less than about 4 mg of slough. All while yielding tissue products that are both thick and soft.

High basis weight tissue with low slough

In general, the present disclosure is directed to creped tissue webs, and products produced therefrom. The creped webs and products are strong, soft, and have fine crepe structure, such as less than about 12, measured as % COV at a STFI wavelength of 16 to 32 mm, using the test method set forth herein. Fine crepe structure is achieved even at basis weights in excess of 16 gsm per ply.

High basis weight creped tissue

In general, the present disclosure is directed to creped tissue webs, and products produced therefrom. The creped webs and products are strong, soft, and have improved strike-through and absorbency properties. The improvement in both strike-through and absorbency is achieved in-part by increasing the basis weight of the web, while at the same time reducing the creping composition add-on levels.

Absorbent barrier tissue

Tissues are provided as multi-ply tissue products having greater tactile sensation and resiliency in hand. Improved tissues may have a thickened and reduced density middle layer. The tissues may serve as applicators for chemical agents to be released during use of the tissue. A tissue having an improved tactile impression to the consumer, with enhanced resilience and high external bulk is disclosed. In one embodiment, a multi-ply structure having at least three plies is desirable. A middle or intermediate ply is comprised an increased thickness and a greater bulk is employed. In general, the exterior plies of the tissue are smooth and desirable to the consumer.

Enhanced multi-ply tissue products

Tissues having a high level of softness and hand protection in combination with improved cleaning are disclosed. The tissues have been shown to remove more mucus than commercially available tissues.

Soft paper sheet with improved mucus removal

A non-irritating multi-ply absorbent article made by treating an inner surface with one or more antimicrobial agents and treating the one or more outer surfaces with one or more siloxane compositions, and methods of making and using the same. The antimicrobial agent will remain confined to the inner portion of the absorbent article, thereby preventing irritation to the user, and the siloxane treated ply(s) will provide a pleasing, soothing, non-irritating tactile quality. In one embodiment, the siloxane composition comprises an amine-modified polysiloxane, in which case the product will also entrap any absorbed fluid, holding it in contact with the antimicrobial agent, and preventing it from wetting through the product and contacting the user.

Antimicrobial absorbent article, and methods of making and using the same

A soothing anti-viral lotion composition and a lotioned tissue product having a surface with the lotion composition applied thereto, and methods for making and using the same. The lotion composition includes an anti-viral organic acid and a topical delivery system. The topical delivery system includes one or more polyesters which allow incorporation of the organic acids into the lotion formulation, controls their delivery, and maintains them in the stratum corneum. The lotion composition may optionally contain a surfactant, an irritation inhibiting agent, and other additives.

Anti-viral lotion tissue, and methods for making and using the same

The present invention relates to a method of sequestering skin irritants with a skin irritant sequestering composition comprising a substrate, a hydrophilic skin irritant sequestering agent and a hydrophobic skin irritant sequestering agent. In one embodiment the sequestering agents are comprised of modified and non-modified clays. The present invention further also provides a method of sequestering skin irritants comprising administering to the stratum corneum of an individual's skin a skin irritant sequestering composition comprising a substrate, a skin irritant sequestering amount of a combination of hydrophilic and hydrophobic skin irritant sequestering agents. In one embodiment the skin irritants are bound to sequestering agents present on a substrate. In another embodiment the skin irritants are bound to sequestering agents present on the skin.

Method for sequestration of skin irritants with substrate compositions

Facial tissue is provided comprising a tissue substrate, a hydrophilic nasal secretion skin irritant sequestering agent and a hydrophobic nasal secretion skin irritant sequestering agent. In one embodiment the sequestering agents are comprised of modified and non-modified clays. In one embodiment the skin irritants are bound to sequestering agents present on a substrate. In another embodiment the skin irritants are bound to sequestering agents present on the skin.

Facial tissue composition for sequestration of nasal secretion skin irritants

The present invention provides a method of sequestering nasal secretion skin irritants comprising administering to the stratum corneum of an individual's skin a facial tissue comprising a tissue substrate, a nasal secretion skin irritant sequestering amount of a combination of hydrophilic and hydrophobic nasal secretion skin irritant sequestering agents. In one embodiment the sequestering agents are comprised of modified and non-modified clays. In one embodiment the skin irritants are bound to sequestering agents present on a substrate. In another embodiment the skin irritants are bound to sequestering agents present on the skin.

Method for sequestration of nasal secretion skin irritants with facial tissue

Growing community of inventors

Fremont, WI, United States of America

Gary Lee Shanklin